What type of study is this?

This is a Human Clinical Trial study.

December 8, 2025BloodOpen Access

Overcoming barriers to clinical trial enrollment among adolescents and young adults with acute myeloid leukemia: Insights from a large academic cancer center

View Full Paper

Ask AI

Bookmark

Authors

MSMahesh SwaminathanThe University of Texas MD Anderson Cancer Center KSKoji SasakiThe University of Texas MD Anderson Cancer Center TKTapan KadiaThe University of Texas MD Anderson Cancer Center

Discussion

Member takes

Implication

Observational analysis shows 71% enrollment in clinical trials among AYAs with AML, highlighting barriers like financial constraints and comorbidities.

Key Points

Clinical trial enrollment in AYAs with acute myeloid leukemia was 71%, indicating significant participation.
Key barriers included financial constraints (33%) and ineligibility due to patient factors (22%).
Retrospective review conducted at MD Anderson Cancer Center over ten years identified enrollment challenges.
Addressing financial constraints and expanding eligibility criteria may enhance access to clinical trials.

Cite This Study

Swaminathan et al. (2025) studied this question.

synapsesocial.com/papers/69362f364fa91c937236d399 https://doi.org/10.1182/blood-2025-4613

View Full Paper

Ask AI

Bookmark

Implication

Observational analysis shows 71% enrollment in clinical trials among AYAs with AML, highlighting barriers like financial constraints and comorbidities.

Overcoming barriers to clinical trial enrollment among adolescents and young adults with acute myeloid leukemia: Insights from a large academic cancer center

Discussion

Member takes

Implication

Key Points

Cite This Study

Overcoming barriers to clinical trial enrollment among adolescents and young adults with acute myeloid leukemia: Insights from a large academic cancer center

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider